2-(4,7-Bis(2-(tert-butoxy)-2-oxoethyl)-1,4,7-triazonan-1-yl)acetic acid, 97%, 50mg

(R,E)-5-([1,1'-Biphenyl]-4-yl)-4-((tert-butoxycarbonyl)amino)-2-methylpent-2-enoic acid, 97.0%, 10g

(1R,2S)-(-)-2-Amino-1,2-diphenylethanol>99.0%(GC)(T)1g

tert-Butyl N-[(3S,4S)-4-hydroxypiperidin-3-yl]carbamate, 95%, 1g

6-Aminopicolinonitrile, 98.0%, 25g

(S)-(-)-2-Aminomethyl-1-ethylpyrrolidine, 95.0%, 5g

(2,5-Dibromophenyl)hydrazine, 95.0%, 1g

1-Methyl-4-(methylamino)pyrrolidin-2-one, 98%, 250mg

Wide mouth bottle square, 500 ml, 48 mm, 12 Piece(s)

4-Nitrophenyl 2-(trimethylsilyl)ethyl carbonate, 95.0%, 1g

1-(3,4-Dichlorophenyl)cyclopropanecarbonitrile, 95%, 1g

5-BROMO-1-METHYL-2-PHENYL-1H-IMIDAZOLE, 95%, 1g

4'-Methoxy-2-phenylacetophenone, 97.0%, 5g